Theme: Exploring the new horizons to cure Hypertension & Cardiac diseases

Hypertension Meeting 2023

Renowned Speakers

Hypertension Meeting 2023

Following the success of the previous conferences, we are excited to announce that 11th International Conference on Hypertension & Healthcare” will be held during November 20-21, 2023 at the most beautifully crafted city of Dubai, UAE. The theme of our conference is Exploring the new horizons to cure Hypertension & Cardiac diseases. Hypertension Meeting 2023 will be an international event focussing on the core knowledge and major advances in the ever-expanding field of Hypertension & Healthcare by attracting experts on a global scale.

This year, we also hope to bring together experiences from different countries and exchange their views, reinforce knowledge base, and learn new concepts. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better diagnosis and treatment of Cardiac Diseases. We sincerely invite you to join us in this very informative annual conference and collaborate in the global action in reducing the burden of Hypertension & cardiovascular diseases. Your presence will certainly add value to the conference and very much appreciated!

ME Conferences through its Open Access Initiative is committed to create real and reliable contributions to the scientific community. Conference Series Ltd organize 600+ Conferences once a year across USA, Europe & Asia with support from a thousand additional scientific societies and Publishes 400+ Open access journals that contains over 30000 eminent personalities, putative scientists as editorial board members.

Why to attend?? 

Encounter the target market with members from across the globe, committed to learn about hypertension treatment and management. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations, distribute and update knowledge about the current situation of hypertension treatment and receive name recognition at this 2 days event. World-eminent speakers, most recent researches, latest treatment techniques and the advanced updates in Hypertension Management are the principal features of this conference.

Target Audience:

Our Organization would be privileged to welcome the:

  • Directors of Hypertension or related Programs or Associations
  • Heads, Deans and Professors of Hypertension or Cardiology departments
  • Scientists and Researchers organizers
  • Doctors
  • Medical Colleges
  • Writers
  • Healthcare professionals
  • Founders and Employees of the related companies
  • Clinical investigators
  • Hospitals and Health Services
  • Pharmaceutical companies
  • Laboratory members
  • Training institutions
  • Support organizers
  • Data Management Companies
  • Cardiologists training and education
  • Nurse and nursing education institutions

Track 1: Hypertension

Hypertension, often known as high blood pressure, is a long-term medical disorder characterized by chronically excessive blood pressure in the arteries. The majority of the time, high blood pressure does not create any symptoms. High blood pressure for an extended period of time, on the other hand, is a substantial risk factor for stroke, coronary artery disease, heart failure, atrial fibrillation, peripheral arterial disease, vision loss, and chronic kidney disease.

  • Fitness & Exercise.
  • Heart Disease.
  • Metabolic Syndrome.   

Track 2: Pediatric Hypertension 

Elevated blood pressure is defined as blood pressure in the 90th percentile or higher for age, height, and sex in children younger than 13 years, while hypertension is defined as blood pressure in the 95th percentile or above. Obesity has become an increasingly important medical problem in children and adolescents. Primary hypertension is detectable in children and adolescents and, as in adults, is associated with a positive family history of hypertension, obesity, and life-style factors. Among children and adolescents with primary hypertension; the presence of obesity was associated with marked LVH. Most childhood hypertension, particularly in preadolescents, is secondary to an underlying disorder.

Track 3: Pulmonary Hypertension

Pulmonary hypertension is a type of high blood pressure that affects the arteries in your lungs and the right side of your heart. In one form of pulmonary hypertension, tiny arteries in your lungs, called pulmonary arterioles, and capillaries become narrowed, blocked or destroyed. In one type of pulmonary hypertension, This makes it harder for blood  to move through the lungs and consequently raises the weight inside lung dividers. As the weight assembles, the heart's lower right chamber works more diligently to siphon blood through the lungs, in the long run causing the heart muscle fall flat. A few types of pulmonary hypertension are serious conditions that become dynamically more awful and are once in a while deadly.

Track 4:  Gestational Hypertension

Gestational Hypertension is also known as pregnancy induced hyper tension, is a group of high blood pressure disorders.. We can find Gestational Hypertension by each prenatal checkup; your healthcare provider will check your blood pressure and urine levels. Your doctor may also check your kidney and blood-clotting functions, order blood tests, perform an ultrasound scan to check your baby’s growth, and use a Doppler Scan to measure the efficiency of blood flow to the placenta. High Blood Pressure (Hypertension) during pregnancy can forestall the placenta (the nourishment supply for the child in the belly) from getting enough blood. The brought measure of blood down to the placenta can prompt a low birth weight.

Track 5: Hypertension Diagnosis 

When blood pressure is always measured at> 130 mmHg systolic blood pressure and> 80 mmHg diastolic blood pressure, it is diagnosed as hypertension. Blood pressure is measured with a blood pressure cuff, which is a non-invasive device that can detect the pressure in the arteries, using a blood pressure meter or electronic equipment to transmit the value. Your doctor may also use laboratory tests or imaging tests to diagnose certain causes or complications of high blood pressure.

Track 6: Hypertension, Stroke & Obesity

Albeit both are associated with hypertension, focal fat circulation might be more firmly connected with stroke hazard than relative weight or weight record. A portion of this connection could be clarified by the way that focal stoutness addresses grown-up weight increment, which might be more applicable to stroke hazard than advanced age weight. Three attributes are connected to focal adiposity, hypertension, and stroke.

Track 7: Hypertension and Race/Ethnicity

Although there are still differences in the prevalence, control, and outcome of HTN compared to non-Hispanic whites, racial / ethnic minorities are underrepresented in genetic and clinical studies. Genomics has improved our understanding of HTN, but it does not have clinically useful applications. The role of social determinants of health in differences in hypertension is increasingly recognized. A team-based approach with targeted interventions at various levels can overcome barriers that have unique effects on minorities / minorities. Pulmonary hypertension in heart failure

Track 8: Source of Hypertension 

A high-salt, high-fat, or potentially elevated cholesterol diet are for the most part normal reasons for hypertension. Kidney and chemical issues, diabetes, and inordinate cholesterol are altogether constant diseases. Hypertension runs in your family, particularly if your folks or other direct relations have it.

  • diet high in salt
  • fat
  • cholesterol

Track 9: Yoga and Naturopathic Treatments

Physiotherapy is an allied health profession that treats impairments and enhances mobility and function by using mechanical force and movements (biomechanics or kinesiology), manual therapy, exercise therapy, and electrotherapy.

Track 10: Nursing Management of Hypertension

Standard office-based approaches to manage hypertension show limited success. Such suboptimal hypertension manage reflects in part the absence of both an infrastructure for patient education and frequent, regular blood pressure  monitoring. We tested the efficacy of a physician-directed, nurse-managed, home-based system for hypertension management with standardized algorithms to modulate drug therapy, based on patients’ reports of home BP.

Track 11: Incidence and Prognosis of Refractory Hypertension in Patients

Among patients with hypertension who initiate treatment, 1 in 50 patients develops refractory hypertension. Patients with refractory hypertension are at increased risk of cardiovascular events, supporting the need for increased efforts to improve hypertension outcome in this population.

Track 12: Reno-Vascular Hypertension

Reno-vascular hypertension is high blood pressure due to narrowing of the arteries that carry blood to the kidneys. This condition is also called renal artery stenosis. Renal hypertension is caused by a narrowing in the arteries that deliver blood to the kidney. One or both kidneys arteries may be narrowed. This is a condition called renal artery stenosis. When the kidneys receive low blood flow, they act as if the low flow is due to dehydration. So they respond by releasing hormones that stimulate the body to retain sodium and water. Blood vessels fill with additional fluid and blood pressure goes up. The narrowing in one or both renal arteries is most often caused by atherosclerosis, or hardening of the arteries

Track 13: Cardio Metabolic Risk in Hypertensive Patients

The Cardio-metabolic and Device therapy is the main risk for the condition in which the possibilities of developing atherosclerotic cardiovascular disease and diabetes mellitus are significantly enhanced as a consequence of the presence of insulin resistance and atherogenic dyslipidaemia, the latter being characterized by the presence of low high-density lipoprotein (HDL) cholesterol and high triglyceride levels. Cardio-metabolic risk is diagnosed by the identification of an enhanced waist circumference accompanied by the alterations in lipid profile quoted above.

Track 14: Cardiac Medications and Device Therapy

Implantable cardiac devices are a mainstay in treating cardiac diseases and include pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy. Some drugs can interfere with these devices, while certain medications can prevent inappropriate shocks from the devices. Type of Cardiac Devices. Many cardiac devices are designed to help control irregular heartbeats in people with heart rhythm disorders. These devices include implantable cardioverter defibrillators, or ICDs, pacemakers, and implanted heart rhythm monitors called loop recorders. Reason for Medication, it helps prevent clotting in patients who have had a heart attack, unstable angina, ischemic strokes, TIA (transient ischemic attacks) and other forms of cardiovascular disease. Can also be prescribed preventively when plaque build-up is evident but there is not yet a major blockage in the artery. Certain patients will be prescribed aspirin combined with another antiplatelet drug also known as dual antiplatelet therapy (DAPT)

Track 15: Effect of Dietary Protein Supplementation on Blood Pressure

The results of this randomized controlled trial showed that in patients with prehypertension and stage 1 hypertension, the intake of soy and milk protein can reduce systolic blood pressure compared with refined high-glycemic carbohydrates. In addition, these findings indicate that substituting soy or milk protein for some carbohydrates may be an important part of nutritional intervention strategies for the prevention and treatment of hypertension.

  • dietary protein
  • carbohydrate
  • hypertension

ME Conferences  feel fortunate to welcome you to be a part of upcoming 11th International Conference on Hypertension and Healthcare  planned to be held in the popular city osaka japan during November 20-21, 2023 in Dubai, UAE. The conference emphasizes the theme Exploring the new horizons to cure Hypertension & Cardiac diseases”.  Hypertension Meeting 2023 welcomes the innovative strategies in the area of hypertension research and also proposes a unique opportunity for the explorers from all over the world to gather, share and perceive new scientific interactions upon the various perceptions of hypertension.

Conference Series Ltd organizes 600+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Importance and scope:

Hypertension is a major risk factor for cardiovascular diseases, cerebrovascular events and ischaemic heart diseases, so is therefore one of the most important preventable causes of premature morbidity and mortality in developed and developing countries. It is often symptomless, so screening is vital before damage is done. Many surveys continue to show that hypertension remains underdiagnosed, undertreated and poorly controlled. Overall, the prevalence of hypertension (at least ≥140/90 mm Hg or on treatment) in those aged over 35 was observed to be 32% in men and 27% in women.

A prospective survey of patients in 20th century electrocardiography, preventive cardiology and the Framingham Study, lipid hypotheses and atherosclerosis, coronary care units, thrombolytic therapy, cardiac catheterization and coronary angiography, open-heart surgery, automatic implantable cardiac defibrillators, and coronary angioplasty. In hypertension, different changes made to the understand the basic levels of blood pressure and in the development of new diagnostic and therapeutic techniques.

Hypertension Meeting 2023 is an international platform for presenting research about Hypertension and related concepts, sharing alternative ideas about the severe cardiovascular risk factor, contributing to the dissemination of information about the trouble for the welfare of the society.

Growth of Interventional Cardiology Market

In 2020, the global interventional cardiology market size was valued at approximately $11.1 billion, down from nearly $14 billion in 2019 due to the impact of COVID-19. The global market size is expected to reach an astonishing $16.2 billion in 2027. Over 40% of the global interventional cardiology market share was controlled by Boston Scientific, Abbott, and Medtronic. This global market research includes an analysis of 46 interventional cardiology companies spawning across more than 70 countries in the world.

The improvement of advanced minimally invasive procedures and increment in the selection of the equivalent in interventional cardiology is probably going to drive the worldwide market later on. Besides, the advancement of crossover strategies is another pattern that is probably going to pick up acknowledgment over the business in the coming years. Expanding number of individuals with heart diseases around the globe ascend in the populace, and development of pediatric heart diseases are a portion of alternate factors that are relied upon to push the advancement of the general interventional cardiology market in a development direction.

In spite of the idealistic development forecast of the interventional cardiology showcase, some limiting components must be thought about while investigating the general market situation. Post-procedural complexities, for example, blood coagulating or thrombosis, uneven medication discharge, and changing rates of corruption are a portion of the components that may block the development of the market. Also, the market situation of interventional cardiology is exceptionally powerful. The force of competition among companies is reasonably high. Value cuts offered by little and medium players on their gadgets constrain built up players to decrease their profit revenues.

List of Cardiology Universities:


  • Osaka Gakuin University
  • Osaka Metropolitan University Sugimoto Campus
  • Hannan University
  • Osaka Seikei University
  • Morinomiya University of Medical Sciences
  • Osaka Jogakuin University / College
  • Osaka International University – Moriguchi Campus
  • Soai University
  • Osaka University of Commerce
  • Osaka University of Economics


World Wide:

  • Academic Medical Centre
  • Medipol University
  • Yeditepe University
  • Okan University
  • Wittenberg University of Applied Sciences
  • Tio University of Applied Sciences
  • University of Groningen
  • Netherlands Heart Institute
  • University of Leiden
  • Yerevan State Medical University
  • Medical University of Graz
  • Paracelsus Private Medical University of Salzburg
  • Universiteit Utrecht
  • University of Groningen
  • University College Roosevelt
  • Wageningen University
  • In Holland University of Applied Sciences
  • Saxion University of Applied Sciences
  • Harvard University
  • University of Oxford
  • University of Cambridge
  • Johns Hopkins University
  • Stanford University
  • Yale University
  • University of California, Los Angeles
  • University of Melbourne
  • University of Geneva
  • University of Bern

Societies Associated with Cardiology:

  • European Society of Cardiology
  • European Atherosclerosis Society
  • Austrian Society of Cardiology
  • German Cardiac Society
  • Italian Federation of Cardiology
  • Spanish Society of Cardiology.

Hospitals Associated with Cardiology:


  • NHO Osaka National Hospital
  • Osaka Central Hospital
  • Osaka City JÅ«sō Hospital
  • Osaka Metropolitan University Hospital
  • Osaka City General Hospital
  • Osaka Red Cross Hospital
  • Sumitomo Hospital
  • JCHO Osaka Hospital
  • Osaka Gyoumeikan Hospital
  • Otemae Clinics
  • ÅŒsaka Ekisaikai Hospital
  • Osaka General Medical Center
  • Osaka Prefecture Saiseikai Noe Hospital
  • Osaka Kaisei Hospital
  • Yodogawa Christian Hospital


  • Cleveland Clinic
  • Mayo Clinic
  • New York-Presbyterian Hospital
  • Cedars-Sinai Medical Center
  • Massachusetts General Hospital
  • Johns Hopkins Hospital
  • Northwestern Memorial Hospital
  • Hospitals of the University of Pennsylvania-Penn Presbyterian
  • Mount Sinai Hospital
  • University of Michigan Hospitals and Health Centers
  • Duke University Hospital
  • Brigham and Women's Hospital
  • Barnes-Jewish Hospital
  • UCLA Medical Center
  • Stanford Health Care-Stanford Hospital
  • Heart Hospital Baylor Plano
  • Houston Methodist Hospital
  • Loyola University Medical Center
  • NYU Langone Medical Center
  • UPMC Presbyterian Shadyside
  • Scripps La Jolla Hospitals
  • Ohio State University Wexner Medical Center
  • UCSF Medical Center
  • Sentara Norfolk General Hospital-Sentara Heart Hospital
  • Texas Heart Institute at Baylor St. Luke's Medical Center
  • Beaumont Hospital-Royal Oak
  • Minneapolis Heart Institute at Abbott Northwestern Hospital
  • Vanderbilt University Medical Center
  • Memorial Hermann-Texas Medical Center
  • The University of Alabama at Birmingham Hospital
  • University of Colorado Hospital
  • St. Francis Hospital

List of Companies Associated with Cardiology:

  • St. Jude Medical
  • Terumo
  • Edwards Life Sciences
  • Abbott Laboratories
  • Johnson & Johnson
  • W. L. Gore & Associates
  • Boston Scientific
  • Medtronic

Related Conferences:

  • 4th World Heart Congress, April 29 - May 01, 2019 ANA Crowne Plaza Kyoto | Kyoto, Japan
  • Middle East Heart Congress, March 18-20, 2019 Dubai, UAE
  • World Congress on Cardiac Surgery & Medical Devices 2019 April 17-18, 2019 Montreal | Quebec, Canada
  • 7th International Conference on Hypertension & Healthcare, June 10-11, 2019 Helsinki, Finland
  • 29th International Conference on Cardiology and Healthcare, June 10-11, 2019 Helsinki, Finland
  • 2nd World Heart and Brain Conference, September 25-26, 2019 Helsinki, Finland
  • 31st Annual Cardiologists Conference, June 17-19, 2019 Rome, Italy
  • 4th International Conference on Cardiovascular Medicine and Cardiac Surgery, July 22-23, 2019 London, UK
  • 27th International Congress on Cardiology and medical interventions, July 31-August 01, 2019 Chicago, Illinois, USA
  • 32nd European Cardiology Conference, October 24-26, 2019 Zurich, Switzerland

Related Societies:

USAThe American Heart AssociationThe American College of Cardiology ,Heart Failure Society of AmericaAmerican Society of EchocardiographyAlliance of Cardiovascular ProfessionalsAmerican College of Chest ProfessionalsAmerican Association of Heart Failure NursesSociety of Invasive Cardiovascular ProfessionalsCardiovascular Credentialing InternationalInternational Academy of CardiologyInternational Society for Heart ResearchSociety of Geriatric CardiologyInternational Society for Minimally Invasive Cardiac SurgeryAmerican College of Cardiovascular Administrators, Brazilian Society of CardiologyHeart and Stroke Foundation of CanadaPulmonary Hypertension Association.

EuropeRussian Society of CardiologyAustrian Heart FoundationBritish Cardiovascular SocietyIrish Nurses Cardiovascular Association,  British Heart FoundationEuropean Society of CardiologyEuropean Stroke Organization,  Albanian Society of Cardiology,  Belorussian Scientific Society of CardiologistsBritish Association of Nursing in Cardiovascular CareHeart Foundation of BotswanaBritish Association of Critical Care NursesCardiology Society of SerbiaSudanese Hypertension SocietyStroke and Vascular MedicineEstonian Society of CardiologyIrish Heart FoundationMoldavian Society of CardiologyMontenegro Society of CardiologyMoroccan Society of CardiologyNorwegian Society of CardiologySaudi Heart AssociationNetherlands Society of CardiologySlovenian Society of Cardiology,  Swedish Society of CardiologyZurich Heart HouseEuropean Atherosclerosis Society.

Middle-EastAlgerian Society of CardiologyRussian Society of CardiologyArmenian Cardiologists AssociationEmirates Cardiac SocietyGulf Heart AssociationTurkish Society of CardiologySaudi Heart AssociationIranian Heart FoundationCyprus Hypertension SocietyEgyptian Cardiology Society,  Israel Heart SocietyKuwait Medical AssociationIraqi Cardiothoracic SocietyIranian Heart Association.

Asia-PacificAsian Pacific Society of CardiologyCameroon Heart FoundationVietnam Heart AssociationAssociation of Pediatric CardiologyIndonesian Heart AssociationHeart Association of Thailand,  The National Heart Association of MalaysiaThe Japanese College of CardiologyCardio metabolic Heart CongressChinese Society of Cardiology,  World Heart FederationPhilippine Heart AssociationChinese Hypertension LeagueHong Kong Society of Pediatric CardiologyTaiwan Society of CardiologyTaiwan Hypertension SocietyThe Japanese Heart Failure SocietyJapanese Heart Rhythm SocietyVietnamese Society of HypertensionSingapore Heart FoundationMacau Cardiology AssociationKyrgyz Society of Cardiology.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 20-21, 2023
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View